BioLife Solutions holder proposes $15.6M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BioLife Solutions Inc. reports that Casdin Partners Master Fund, L.P., a 10% shareholder, filed a notice of a proposed sale of 650,000 common shares, with an approximate sale date of May 21, 2026. The notice lists an aggregate market value of $15.6 million and names BMO Capital Markets as broker. The fund acquired 650,000 shares directly from the issuer for cash on August 13, 2018. It also lists the fund's sales of 300,000 shares for gross proceeds of $6,795,000 on May 19, 2026, and 250,000 shares for gross proceeds of $5,925,000 on May 20, 2026. Eli Casdin signed the notice.
Key Figures
Key Terms
Aggregate Market Value financial
Gross Proceeds financial
par value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Which broker is named for Casdin Partners Master Fund's proposed BLFS sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.